Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,506,147,163
+$377,866,226 QoQ
Shares Held
1,255,719
+2.4% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#66
of 4,632 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $4,805,415,142 across 12 Drug Manufacturers - General names. LLY ranks #1 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,255,719 | $1,506,147,163 | |
| 2 | JNJ |
Johnson & Johnson
|
3,383,935 | $859,417,971 | |
| 3 | ABBV |
AbbVie Inc.
|
2,684,208 | $675,454,100 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,751,479 | $610,565,050 | |
| 5 | NVS |
Novartis AG
|
1,565,796 | $245,391,548 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,793,779 | $226,626,038 | |
| 7 | AMGN |
Amgen Inc
|
614,341 | $222,465,162 | |
| 8 | PFE |
Pfizer Inc
|
6,346,636 | $152,826,994 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,506,147,163 | 1,255,719 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,128,280,937 | 1,226,699 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $1,364,339,701 | 1,269,531 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $956,566,233 | 1,253,691 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $967,971,242 | 1,241,737 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,060,711,256 | 1,284,294 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $997,005,576 | 1,291,458 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $1,070,698,356 | 1,208,545 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $1,039,592,625 | 1,148,239 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $947,216,866 | 1,217,565 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $713,572,190 | 1,224,134 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $669,968,156 | 1,247,311 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $581,449,375 | 1,239,817 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $429,976,949 | 1,252,044 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $477,308,520 | 1,304,692 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $431,807,085 | 1,335,417 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $413,568,657 | 1,275,541 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $411,378,236 | 1,436,527 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $402,072,184 | 1,455,623 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $329,779,512 | 1,427,308 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $305,615,289 | 1,331,541 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $237,966,084 | 1,273,772 | Shares | Defined | 2021-05-10 | |
| 2020-09-30 | $213,758,050 | 1,444,116 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $255,816,246 | 1,558,145 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $171,875,744 | 1,239,012 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||